The awards are back - New Zealand Primary Healthcare Awards

Fighting cognitive decline: Helpful herbs

+Natural health
In print
EDUCATION

Fighting cognitive decline: Helpful herbs

March 2023

Phil Rasmussen

Wednesday 1 March 2023, 12:30 AM
Lion’s mane (Hericium erinaceus) mushrooms
Lion’s mane (Hericium erinaceus) mushrooms [Image: iStock.com – nortongo]

As more of us live longer, the number of people with cognitive impairments due to ageing or medical conditions also increases. Pharmacist and medical herbalist Phil Rasmussen, looks at herbs having positive effects or showing promise in this area

Brain health is becoming more important as ageing populations and improved medical treatments mean the number of people with cognitive impairments, su
References
  1. World Alzheimer Report 2016.
  2. Hadley G, Zhang J, Harris-Skillman E, et al. Cognitive decline and diabetes: a systematic review of the neuropathological correlates accounting for cognition at death. J Neurol Neurosurg Psychiatry 2022;93(3):246–53.
  3. Pistollato F, Iglesias RC, Ruiz R, et al. Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer’s disease: A focus on human studies. Pharmacol Res 2018;131:32–43.
  4. Kępka A, Ochocińska A, Borzym-Kluczyk M, et al. Healthy Food Pyramid as Well as Physical and Mental Activity in the Prevention of Alzheimer’s Disease. Nutrients 2022;14(8):1534.
  5. Zhou A, Taylor AE, Karhunen V, et al. Habitual coffee consumption and cognitive function: a Mendelian randomization meta-analysis in up to 415,530 participants. Sci Rep 2018;8(1):7526.
  6. Londzin P, Zamora M, Kąkol B, et al. Potential of Caffeine in Alzheimer's Disease – A Review of Experimental Studies. Nutrients 2021;13(2):537.
  7. Santos C, Costa J, Santos J, et al. Caffeine intake and dementia: systematic review and meta-analysis. J Alzheimers Dis 2010;20 Suppl 1:S187–204.
  8. Kakutani S, Watanabe H, Murayama N. Green Tea Intake and Risks for Dementia, Alzheimer's Disease, Mild Cognitive Impairment, and Cognitive Impairment: A Systematic Review. Nutrients 2019;11(5):1165.
  9. Unno K, Nakamura Y. Green Tea Suppresses Brain Aging. Molecules 2021;26(16):4897. Published 2021 Aug 12. Ng QX, Loke W, Foo NX, et al. A systematic review of the clinical use of Withania somnifera (Ashwagandha) to ameliorate cognitive dysfunction. Phytother Res 2020;34(3):583–90.
  10. Dietz C, Dekker M. Effect of Green Tea Phytochemicals on Mood and Cognition. Curr Pharm Des 2017;23(19):2876–905.
  11. Panza F, Solfrizzi V, Barulli MR, et al. Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review. J Nutr Health Aging 2015;19(3):313–28.
  12. Tan MS, Yu JT, Tan CC, et al. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. J Alzheimers Dis 2015;43(2):589–603.
  13. Kandiah N, Chan YF, Chen C, et al. Strategies for the use of Ginkgo biloba extract, EGb 761®, in the treatment and management of mild cognitive impairment in Asia: Expert consensus. CNS Neurosci Ther 2021;27(2):149–62.
  14. Vellas B, Coley N, Ousset PJ, et al. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol 2012;11(10):851–59.
  15. Yang G, Wang Y, Sun J, et al. Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Curr Top Med Chem 2016;16(5):520–28.
  16. Oskouei DS, Rikhtegar R, Hashemilar M, et al. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial. J Stroke Cerebrovasc Dis 2013;22(8):e557–63.
  17. Li S, Zhang X, Fang Q, et al. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial. Stroke Vasc Neurol 2017;2(4):189–97.
  18. Ji H, Zhou X, Wei W, et al. Ginkgo Biloba extract as an adjunctive treatment for ischemic stroke: A systematic review and meta-analysis of randomized clinical trials. Medicine (Baltimore) 2020;99(2):e18568.
  19. DeKosky ST, Williamson JD, Fitzpatrick AL, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 2008;300(19):2253–62.
  20. Rasmussen PL. Ginkgo fails clinical trial for dementia prevention. Phytonews 31, March 2009.
  21. Kongkeaw C, Dilokthornsakul P, Thanarangsarit P, et al. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. J Ethnopharmacol 2014;151(1):528–35.
  22. Dubey T, Chinnathambi S. Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer's disease. Arch Biochem Biophys 2019;676:108153.
  23. Prabhakar S, Vishnu VY, Modi M, et al. Efficacy of Bacopa Monnieri (Brahmi) and Donepezil in Alzheimer’s Disease and Mild Cognitive Impairment: A Randomized Double-Blind Parallel Phase 2b Study. Ann Indian Acad Neurol 2020;23(6):767–73.
  24. Basheer A, Agarwal A, Mishra B, et al. Use of Bacopa monnieri in the Treatment of Dementia Due to Alzheimer Disease: Systematic Review of Randomized Controlled Trials. Interact J Med Res 2022;11(2):e38542.
  25. Aguiar S, Borowski T. Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation Res 2013;16(4):313–26.
  26. Bautista-González JA, Montoya A, Bye R, et al. Traditional knowledge of medicinal mushrooms and lichens of Yuman peoples in Northern Mexico. J Ethnobiology Ethnomedicine 2022;18:52.
  27. Lorca C, Mulet M, Arévalo-Caro C, et al. Plant-derived nootropics and human cognition: A systematic review. Crit Rev Food Sci Nutr; 3 January 2022 online.
  28. Bishop KS, Kao CH, Xu Y, et al. From 2000 years of Ganoderma lucidum to recent developments in nutraceuticals. Phytochemistry 2015;114:56–65.
  29. Lv Q, Di X, Bian B, et al. Neuroprotective Effects of Poria cocos (Agaricomycetes) Essential Oil on Aβ1-40-Induced Learning and Memory Deficit in Rats. Int J Med Mushrooms 2022;24(10):73–82.
  30. Shimbo M, Kawagishi H, Yokogoshi H. Erinacine A increases catecholamine and nerve growth factor content in the central nervous system of rats. Nutrition Research 2005;25(6):617–23.
  31. Tsai-Teng T, Chin-Chu C, Li-Ya, L, et al. Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer's disease-related pathologies in APPswe/PS1dE9 transgenic mice. J Biomed Sci 2016;23(1):49.
  32. Tzeng TT, Chen CC, Tsay HJ, et al. The Cyanthin Diterpenoid and Sesterterpene Constituents of Hericium erinaceus Mycelium Ameliorate Alzheimer's Disease-Related Pathologies in APP/PS1 Transgenic Mice. Int J Mol Sci 2018:19(2):598.
  33. Zhang J, An S, Hu W, et al. The Neuroprotective Properties of Hericium erinaceus in Glutamate-Damaged Differentiated PC12 Cells and an Alzheimer's Disease Mouse Model. Int J Mol Sci 2016:17(11):1810.
  34. Cordaro M, Salinaro AT, Siracusa R, et al. Key Mechanisms and Potential Implications of Hericium erinaceus in NLRP3 Inflammasome Activation by Reactive Oxygen Species during Alzheimer’s Disease. Antioxidants (Basel, Switzerland) 2021:10(11):1664.
  35. Li IC, Chang HH, Lin CH, et al. Prevention of Early Alzheimer’s Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study. Front Aging Neurosci 2020;12:155.
  36. Mori K, Inatomi S, Ouchi K, et al. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res 2009;23(3):367–72.
  37. Saitsu Y, Nishide A, Kikushima K, et al. Improvement of cognitive functions by oral intake of Hericium erinaceus. Biomed Res 2019;40(4):125–31.
  38. Li IC, Chang HH, Lin CH, et al. Prevention of Early Alzheimer’s Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study. Front Aging Neurosci 2020;12:155.
  39. Wang N, Tian Y, Yan F, et al. Berberine protects against chronic cerebral hypoperfusion-induced cognitive impairment and hippocampal damage via regulation of the ERK/Nrf2 pathway. J Chem Neuroanat 2022;123:102119.
  40. Sahu K, Singh S, Devi B, et al. A Review on the Neuroprotective Effect of Berberine against Chemotherapy- induced Cognitive Impairment. Curr Drug Targets 2022;23(9):913–23.
  41. Shaker FH, El-Derany MO, Wahdan SA, et al. Berberine ameliorates doxorubicin-induced cognitive impairment (chemobrain) in rats. Life Sci 2021;269:119078.
  42. Zhang JH, Zhang JF, Song J, et al. Effects of Berberine on Diabetes and Cognitive Impairment in an Animal Model: The Mechanisms of Action. Am J Chin Med 2021;49(6):1399–415.
  43. Ou X, Hua Y, Liao X, et al. Cognitive impairments induced by severe acute pancreatitis are attenuated by berberine treatment in rats. Mol Med Rep 2018;18(3):3437–44.
  44. Yu Y, Zhao Y, Teng F, et al. Berberine Improves Cognitive Deficiency and Muscular Dysfunction via Activation of the AMPK/SIRT1/PGC-1a Pathway in Skeletal Muscle from Naturally Aging Rats. J Nutr Health Aging 2018;22(6):710–17.
  45. Zhang Z, Li X, Li F, An L. Berberine alleviates postoperative cognitive dysfunction by suppressing neuroinflammation in aged mice. Int Immunopharmacol 2016;38:426–33.
  46. Hao Y, Li J, Yue S, et al. Neuroprotective Effect and Possible Mechanisms of Berberine in Diabetes-Related Cognitive Impairment: A Systematic Review and Meta-Analysis of Animal Studies. Front Pharmacol 2022;13:917375.
  47. Carey AN, Gildawie KR, Rovnak A, et al. Blueberry supplementation attenuates microglia activation and increases neuroplasticity in mice consuming a high-fat diet. Nutr Neurosci 2019;22(4):253–63.
  48. Shimada M, Maeda H, Nanashima N, et al. Anthocyanin-rich blackcurrant extract improves long-term memory impairment and emotional abnormality in senescence-accelerated mice. J Food Biochem 2022;46(10):e14295.
  49. Bonyadi N, Dolatkhah N, Salekzamani Y, Hashemian M. Effect of berry-based supplements and foods on cognitive function: a systematic review. Sci Rep 2022;12(1):3239.
  50. Huang F, Marungruang N, Kostiuchenko O, et al. Identification of Nordic Berries with Beneficial Effects on Cognitive Outcomes and Gut Microbiota in High-Fat-Fed Middle-Aged C57BL/6J Mice. Nutrients 2022;14(13):2734.
  51. Watson AW, Okello EJ, Brooker HJ, et al. The impact of blackcurrant juice on attention, mood and brain wave spectral activity in young healthy volunteers. Nutr Neurosci 2019;22(8):596–606.
  52. Gibson N, Baker D, Sharples A, Braakhuis A. Improving Mental Performance in an Athletic Population with the Use of Ārepa®, a Blackcurrant Based Nootropic Drink: A Randomized Control Trial. Antioxidants (Basel) 2020;9(4):316.
  53. Remenapp A, Coyle K, Orange T, et al. Efficacy of Withania somnifera supplementation on adult's cognition and mood. J Ayurveda Integr Med 2022;13(2):100510.
  54. Gopukumar K, Thanawala S, Somepalli V, et al. Efficacy and Safety of Ashwagandha Root Extract on Cognitive Functions in Healthy, Stressed Adults: A Randomized, Double-Blind, Placebo-Controlled Study. Evid Based Complement Alternat Med 2021;2021:8254344.
  55. Choudhary D, Bhattacharyya S, Bose S. Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions. J Diet Suppl 2017;14(6):599–612.
  56. Ng QX, Loke W, Foo NX, et al. A systematic review of the clinical use of Withania somnifera (Ashwagandha) to ameliorate cognitive dysfunction. Phytother Res 2020;34(3):583–90.
  57. Das R, Rauf A, Akhter S, et al. Role of Withaferin A and Its Derivatives in the Management of Alzheimer's Disease: Recent Trends and Future Perspectives. Molecules 2021;26(12):3696.
  58. Dar NJ, MuzamilAhmad. Neurodegenerative diseases and Withania somnifera (L.): An update. J Ethnopharmacol 2020;256:112769.
  59. Moss M, Smith E, Milner M, McCready J. Acute ingestion of rosemary water: Evidence of cognitive and cerebrovascular effects in healthy adults. J Psychopharmacol 2018;32(12):1319–29.
  60. Perry NSL, Menzies R, Hodgson F, et al. A randomised double-blind placebo-controlled pilot trial of a combined extract of sage, rosemary and melissa, traditional herbal medicines, on the enhancement of memory in normal healthy subjects, including influence of age. Phytomedicine 2018;39:42–48.
  61. Hussain SM, Syeda AF, Alshammari M, et al. Cognition enhancing effect of rosemary (Rosmarinus officinalis L.) in lab animal studies: a systematic review and meta-analysis. Braz J Med Biol Res 2022;55:e11593.
  62. Pengelly A, Snow J, Mills SY, et al. Short-term study on the effects of rosemary on cognitive function in an elderly population. J Med Food 2012;15(1):10–17.
  63. Tsai JH, Huang CF, Lin MN, et al. Taiwanese Vegetarians are Associated with Lower Dementia Risk: A Prospective Cohort Study. Nutrients 2022;14(3):588.

Class

Non-Hodgkin lymphoma

CLASStime: Non-Hodgkin lymphoma

Academic pharmacist Nataly Martini highlights the importance of understanding non-Hodgkin lymphoma and pharmacists’ roles in managing this condition

Read more
Friday 1 November 2024, 01:00 AM
14 minutes to Read
More Class Articles

Latest news

How prepared is pharmacy, 18 months after Cyclone Gabrielle?

04/11/2024

Invercargill pharmacy gets in festive spirit with Santa’s letterbox 

04/11/2024

Pharmacy Council opens submissions on proposed APC increase 

01/11/2024

Pharmacies provide nearly 500,000 flu vaccine shots this year

31/10/2024

Concerns raised over sale of STI self-test kits

29/10/2024

Pharmacists at a loss over CGM remuneration model 

25/10/2024

Hosted Content 2

Man with toilet paper suffering from hemorrhoid

Helping patients leave pain behind

Talking about butt stuff in the pharmacy can be awkward. Care Pharmaceuticals and Rectogesic® can help you get to the bottom of the issue

Read more
Hosted Content by Care Pharmaceuticals
Monday 1 July 2024, 08:00 AM
1 minute to Read

Facebook

Pharmacy Today

Latest issue

PT November 2024_Cover

November 2024

View all issues